Home › Trial NCT02841332
Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
- Trial IDNCT02841332
- StatusTerminated
- PhaseN/A
- Study typeInterventional
- SponsorUniversity Hospital, Toulouse
- Enrollment6
- Start date2013-05
- ConditionsGlioblastoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.